Cost-effectiveness analysis of arthroscopic injection of a bioadhesive hydrogel implant in conjunction with microfracture for the treatment of focal chondral defects of the knee – an Australian perspective

References

• Gorbachova T, Melenevsky Y, Cohen M, et al. Osteochondral lesions of the knee: differentiating the most common entities at MRI. Radiographics. 2018;38(5):712–1495. 2018/09/01
   Web of Science ®Google Scholar
• Wells D. Osteochondral Defect of the Knee [cited 2021 Sept 07]. Available from: https://www.atlasorthopaedics.com/osteochondral-defect-knee-orthopaedic-surgeon-woodstock-ga.html.
   Google Scholar
• Stanford Healthcare. Chondral/Osteochondral Defect [cited 2021 Sept 07]. Available from: https://stanfordhealthcare.org/medical-conditions/bones-joints-and-muscles/chondral-osteochondral-defect.html.
   Google Scholar
• Howell M, Liao Q, Gee CW. Surgical management of osteochondral defects of the knee: an educational review. Curr Rev Musculoskelet Med. 2021;14(1):60–66.
   PubMed Web of Science ®Google Scholar
• Bruns J, Werner M, Habermann C. Osteochondritis dissecans: etiology, pathology, and imaging with a special focus on the knee joint. Cartilage. 2018;9(4):346–362.
   PubMed Web of Science ®Google Scholar
• Gracitelli GC, Moraes VY, Franciozi CE, et al. Surgical interventions (microfracture, drilling, mosaicplasty, and allograft transplantation) for treating isolated cartilage defects of the knee in adults. Cochrane Database Syst Rev. 2016;9(9):Cd010675.
   PubMedGoogle Scholar
• Outerbridge RE. The etiology of chondromalacia patellae. J Bone Joint Surg Br. 1961;43-B:752–757.
   PubMed Web of Science ®Google Scholar
• Henn RF 3rd, Gomoll AH. A review of the evaluation and management of cartilage defects in the knee. Phys Sportsmed. 2011;39(1):101–107.
   PubMed Web of Science ®Google Scholar
• Pipino G, Risitano S, Alviano F, et al. Microfractures and hydrogel scaffolds in the treatment of osteochondral knee defects: a clinical and histological evaluation. J Clin Orthop Trauma. 2019;10(1):67–75.
   PubMedGoogle Scholar
• Stanish WD, McCormack R, Forriol F, et al. Novel scaffold-based BST-CarGel treatment results in superior cartilage repair compared with microfracture in a randomized controlled trial. J Bone Joint Surg Am. 2013;95(18):1640–1650.
   PubMedGoogle Scholar
• Shive MS, Stanish WD, McCormack R, et al. BST-CarGel® treatment maintains cartilage repair superiority over microfracture at 5 years in a multicenter randomized controlled trial. Cartilage. 2015;6(2):62–72.
   PubMed Web of Science ®Google Scholar
• MEDICWAVE. JOINTREP™ Cartilage Regeneration Technology [cited 2021 Sept 07]. Available from: https://medicwave.com.my/jointrep/.
   Google Scholar
• Methot S, Changoor A, Tran-Khanh N, et al. Osteochondral biopsy analysis demonstrates that BST-CarGel treatment improves structural and cellular characteristics of cartilage repair tissue compared with Microfracture. Cartilage. 2016;7(1):16–28.
   PubMed Web of Science ®Google Scholar
• Fravel J, Shaffer M. Rehabilitation following microfracture surgery 2011. [cited 2021 Sept 07]. Available from: https://lermagazine.com/article/rehabilitation-following-microfracture-surgery.
   Google Scholar
• Australian Government Department of Health. Prostheses List [cited 2021 Sept 07]. Available from: https://www.health.gov.au/resources/publications/prostheses-list.
   Google Scholar
• Australian Government Department of Health. Prostheses cover under private health insurance [cited 2021 Sept 07]. Available from: https://www.health.gov.au/health-topics/private-health-insurance/what-private-health-insurance-covers/prostheses-cover-under-private-health-insurance?utm_source=health.gov.au&utm_medium=callout-auto-custom&utm_campaign=digital_transformation.
   Google Scholar
• Australian Government. Private Health Insurance Act 2007 [cited 2021 Sept 07]. Available from: https://www.legislation.gov.au/Details/C2019C00067.
   Google Scholar
• Australian Government Department of Health, Therapeutic Goods Administration. Australian regulatory guidelines for medical devices (ARGMD) [cited 2021 Sept 07]. Available from: https://www.tga.gov.au/publication/australian-regulatory-guidelines-medical-devices-argmd.
   Google Scholar
• Australian Government Department of Health. Prostheses List Advisory Committee (PLAC) [cited 2021 Sept 07]. Available from: https://www.health.gov.au/committees-and-groups/prostheses-list-advisory-committee-plac.
   Google Scholar
• Medina J, Garcia-Mansilla I, Fabricant PD, et al. Microfracture for the treatment of symptomatic cartilage lesions of the knee: a survey of international cartilage regeneration & joint preservation society. Cartilage. 2021;13(1_suppl):1148S–1155S.
   PubMed Web of Science ®Google Scholar
• Medical Services Advisory Committee Australia. Technical Guidelines for preparing assessment reports for the Medical Services Advisory Committee – Service Type: Investigative (Version 3.0). [cited 2021 Sept 07]. Available from: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/0BD63667C984FEEACA25801000123AD8/$File/InvestigativeTechnicalGuidelines-December-2016-Version-3.0.pdf.
   Google Scholar
• The Pharmaceutical Benefits Advisory Committee Australia. Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee (Version 5.0). [cited 2021 Sept 07]. Available from: https://pbac.pbs.gov.au/content/information/files/pbac-guidelines-version-5.pdf.
   Google Scholar
• Australian Bureau of Statistics. Life tables [cited 2021 Nov 20]. Available from: https://www.abs.gov.au/statistics/people/population/life-tables/2018-2020.
   Google Scholar
• Fang WH, Huang GS, Chang HF, et al. Gender differences between WOMAC index scores, health-related quality of life and physical performance in an elderly Taiwanese population with knee osteoarthritis. BMJ Open. 2015;5(9):e008542.
   PubMed Web of Science ®Google Scholar
• Pipino G, Risitano S, Alviano F, et al. Patient level data analyses from: microfractures and hydrogel scaffolds in the treatment of osteochondral knee defects: a clinical and histological evaluation. J Clin Orthop Trauma. 2019;10(1):67–75.
   PubMedGoogle Scholar
• Wailoo A, Hernandez Alava M, Escobar Martinez A. Modelling the relationship between the WOMAC osteoarthritis index and EQ-5D. Health Qual Life Outcomes. 2014;12:37.
   PubMed Web of Science ®Google Scholar
• Viney R, Norman R, Brazier J, et al. An Australian discrete choice experiment to value eq-5d health states. Health Econ. 2014;23(6):729–742.
   PubMed Web of Science ®Google Scholar
• Viney R, Norman R, King MT, et al. Time trade-off derived EQ-5D weights for Australia. Value Health. 2011;14(6):928–936.
   PubMed Web of Science ®Google Scholar
• Clemens S, Begum N, Harper C, et al. A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA. Qual Life Res. 2014;23(8):2375–2381.
   PubMed Web of Science ®Google Scholar
• McCaffrey N, Kaambwa B, Currow DC, et al. Health-related quality of life measured using the EQ-5D-5L: South Australian Population Norms. Health Qual Life Outcomes. 2016;14(1):133.
   PubMedGoogle Scholar
• Mather RC, 3rd, Hug KT, Orlando LA, et al. Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty. BMC Musculoskelet Disord. 2014;15:22.
   PubMed Web of Science ®Google Scholar
• Frappier J, Stanish W, Brittberg M, et al. Economic evaluation of BST-CarGel as an adjunct to microfracture vs microfracture alone in knee cartilage surgery. J Med Econ. 2014;17(4):266–278.
   PubMedGoogle Scholar
• IHPA. National Hospital Cost Data Collection Report, Public Sector, Round 23 (Financial year 2018–19) [cited 2021 Sept 07]. Available from: https://www.ihpa.gov.au/publications/national-hospital-cost-data-collection-report-public-sector-round-23-financial-year.
   Google Scholar
• IHPA. National Efficient Price Determination 2021–22 [cited 2021 Sept 07]. Available from: https://www.ihpa.gov.au/publications/national-efficient-price-determination-2021-22.
   Google Scholar
• Australian Government Department of Health. Medicare Benefits Schedule Handbook. November 2021 [cited 2021 Sept 07]. Available from: http://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/Downloads-211101.
   Google Scholar
• Australian Government Department of Health. Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) [cited 2021 Sept 07]. Available from: https://pbac.pbs.gov.au/.
   Google Scholar
• Australian Government Department of Health. Guidelines for preparing assessments for the MSAC [cited 2021 Sept 07]. Available from: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/MSAC-Guidelines.
   Google Scholar
• Australian Government Department of Health. Prostheses List Guide [cited 2021 Sept 07]. Available from: https://www.health.gov.au/resources/publications/prostheses-list-guide.
   Google Scholar
• Pharmaceutical Benefits Scheme. OLAPARIB, 50 mg capsule, 4 x 112, Lynparza®, AstraZeneca Pty Ltd- Public Summary Document. March 2016. [cited 2021 Sept 07]. Available from: https://www.pbs.gov.au/industry/listing/elements/pbac-meetings/psd/2016-03/files/olaparib-psd-march-2016.pdf.
   Google Scholar
• Ebert JR, Fallon M, Zheng MH, et al. A randomized trial comparing accelerated and traditional approaches to postoperative weightbearing rehabilitation after matrix-induced autologous chondrocyte implantation: findings at 5 years. Am J Sports Med. 2012;40(7):1527–1537.
   PubMed Web of Science ®Google Scholar
• Henderson IJ, Lavigne P. Periosteal autologous chondrocyte implantation for patellar chondral defect in patients with normal and abnormal patellar tracking. Knee. 2006;13(4):274–279.
   PubMed Web of Science ®Google Scholar
• Henderson IJ, Tuy B, Connell D, et al. Prospective clinical study of autologous chondrocyte implantation and correlation with MRI at three and 12 months. J Bone Joint Surg Br. 2003;85(7):1060–1066.
   PubMedGoogle Scholar